학술논문
TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical models
Document Type
Article
Author
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, April 2019, 18(4):733-742)
Subject
Language
English
ISSN
15388514
15357163
15357163